Skip to content
Register Sign in Wishlist

Drugs, Money, and Secret Handshakes
The Unstoppable Growth of Prescription Drug Prices

$24.00 ( ) USD

  • Author: Robin Feldman, University of California, Hastings College of the Law
  • Date Published: April 2019
  • availability: This ISBN is for an eBook version which is distributed on our behalf by a third party.
  • format: Adobe eBook Reader
  • isbn: 9781108759106

$ 24.00 USD ( )
Adobe eBook Reader

You will be taken to for this purchase
Buy eBook Add to wishlist

Other available formats:

Looking for an examination copy?

If you are interested in the title for your course we can consider offering an examination copy. To register your interest please contact providing details of the course you are teaching.

Product filter button
About the Authors
  • In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut out of the market. In Drugs, Money and Secret Handshakes, Robin Feldman shines a light into the dark corners of the pharmaceutical industry to expose a web of shadowy deals in which higher-priced drugs receive favorable treatment and patients are channeled toward the most expensive medicines. At the center of this web are the highly secretive middle players who establish coverage levels for patients and negotiate with drug companies. By offering lucrative payments to these middle players (as well as to doctors and hospitals), drug companies ensure that inexpensive drugs never gain traction. This system of perverse incentives has delivered the kind of exorbitant drug prices - and profits - that everyone loves except for those who pay the bills.

    • Exposes the system of secretive drug pricing deals that is driving high drug prices
    • Describes complex topic of drug pricing in simple, straightforward language
    • The book is academically rigorous while completely accessible, providing information that is fully substantiated and explored through thoughtful logic
    Read more

    Reviews & endorsements

    'This is the book the pharmaceutical industry does not want you to read. Feldman is like a detective, teasing out drug-industry secrets and helping the reader navigate the Alice-in-Wonderland world of drug prices.' David Kessler, Former Commissioner, United States Food and Drug Administration

    'In this lucid and supremely upsetting book, Robin Feldman lays bare the multilayered, perverse incentives that reward pharmaceutical companies for hiking their branded drug prices into the stratosphere. Both houses of Congress should be locked in a room until they've read this book and enacted the remedies she proposes. Prosecutors should read it carefully, too.' Roger Parloff, Legal Journalist

    See more reviews

    Customer reviews

    Not yet reviewed

    Be the first to review

    Review was not posted due to profanity


    , create a review

    (If you're not , sign out)

    Please enter the right captcha value
    Please enter a star rating.
    Your review must be a minimum of 12 words.

    How do you rate this item?


    Product details

    • Date Published: April 2019
    • format: Adobe eBook Reader
    • isbn: 9781108759106
    • contains: 6 b/w illus. 6 tables
    • availability: This ISBN is for an eBook version which is distributed on our behalf by a third party.
  • Table of Contents

    1. Introduction
    2. The landscape – where do the dollars flow
    3. PBMs and insurers
    4. Pharmacies, doctors, and patient groups
    5. May your drug price be ever green
    6. Solutions.

  • Author

    Robin Feldman, University of California, Hastings College of the Law
    Robin Feldman is the Arthur J. Goldberg Distinguished Professor of Law at the University of California Hastings. She is an award-winning scholar whose work has been called 'absolutely remarkable' and a 'must read'. Feldman has published four books and more than fifty articles, and she has been cited by the White House and members of Congress. In 2017, she participated in the GAO's report to Congress on Artificial Intelligence and in an Army Cyber Institute threatcasting exercise on weaponization of data.

Sign In

Please sign in to access your account


Not already registered? Create an account now. ×

Sorry, this resource is locked

Please register or sign in to request access. If you are having problems accessing these resources please email

Register Sign in
Please note that this file is password protected. You will be asked to input your password on the next screen.

» Proceed

You are now leaving the Cambridge University Press website. Your eBook purchase and download will be completed by our partner Please see the permission section of the catalogue page for details of the print & copy limits on our eBooks.

Continue ×

Continue ×

Continue ×

Find content that relates to you

Join us online

This site uses cookies to improve your experience. Read more Close

Are you sure you want to delete your account?

This cannot be undone.


Thank you for your feedback which will help us improve our service.

If you requested a response, we will make sure to get back to you shortly.

Please fill in the required fields in your feedback submission.